Neoleukin Therapeutics, Inc. (NLTX) Covered Calls

You can sell covered calls on Neoleukin Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NLTX (prices last updated Fri 4:16 PM ET):

Neoleukin Therapeutics, Inc. (NLTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.45 +0.01 0.45 0.52 23K - 0.0
Covered Calls For Neoleukin Therapeutics, Inc. (NLTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 16 2.5 0.00 0.52 0.0% 0.0%
Jan 20 2.5 0.00 0.52 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.